glp-1 health risks medication side effects for diabetes and weight loss Nutritional & Botanical Support For

Claim CME for this episode HERE

These figures are from a published randomized controlled trial of the FDA-approved branded drug

And so, really, clients want to make sure that these being again, it goes back to, you know, making sure these drugs are being used appropriately and that that its not just waste within the the system or within the the budget because its, you know, very significant dollars that were talking about, you know, in addition to people wanting to just manage their their overall condition and and, know, live healthier lives

Phase 3 trials evaluating oral semaglutide in early-stage symptomatic Alzheimers disease did not meet their primary endpoints, tempering the earlier hypothesis that GLP-1s might offer direct neuroprotective benefits

Why Microdosing

Resistance exercise remains the most effective non-pharmacological intervention for preserving lean mass during periods of caloric restriction, and a 2022 systematic review and meta-analysis published in Obesity Reviews confirmed that resistance training significantly attenuates lean mass loss during hypocaloric periods, with the most pronounced effects seen when combined with adequate protein intake.7 Clinical note The protein guidance remains unchanged and, if anything, more relevant than ever: a target of 1.2 to 1.6 grams of protein per kilogram of body weight per day during active weight loss continues to be one of the most commonly under-met targets among GLP-1 patients, largely because appetite suppression makes reaching these targets without deliberate planning genuinely difficult.8 As emerging pharmacological options for muscle preservation move closer to clinical practice, they should be understood as additive to this foundation, not a substitute for it